Boston, MA May 1, 2023 – The Police Assisted Addiction and Recovery Initiative (PAARI) is excited to announce the appointment of Louis E. Baxter, Sr., M.D. to its board beginning in May. As a member of the board, Dr. Baxter will aid in the decision-making processes that affect PAARI programming on a daily basis. “I […]
PAARI Announces Upcoming Partner Spotlight Series Guests
BOSTON, MA April 24, 2023 – The Police Assisted Addiction and Recovery Initiative (PAARI) is excited to announce the upcoming guests for the Partner Spotlight Series, a program launched in 2023 that highlights a deserving partner once per month who is running an excellent PAARI model program. The series takes place on the last […]
PAARI Hosts First New Jersey Statewide Convening
On April 18, 2023, The Police Assisted Addiction and Recovery Initiative (PAARI) hosted a virtual statewide convening among New Jersey law enforcement agencies and treatment providers. This convening was designed to allow New Jersey PAARI partners, and those interested in becoming partners, to connect with like-minded agencies in implementing non-arrest programming for those with substance […]
PAARI Announces Launch of Xylazine Study with Brandeis University and Thomas Jefferson University
BOSTON, MA April 10, 2023 – The Police Assisted Addiction and Recovery Initiative (PAARI) is excited to announce the launch of a xylazine pilot project in partnership with Brandeis University and Thomas Jefferson University. The goal of the project is to help PAARI partners address the emerging threat of xylazine, an animal sedative that is […]
The Police Assisted Addiction and Recovery Initiative Appoints Annette Kahrs to Executive Board
Boston, MA April, 4th 2023 – The Police Assisted Addiction and Recovery Initiative (PAARI) is excited to announce the appointment of Annette Kahrs to the Executive Board effective immediately. As a member of the board, Kahrs will aid in the decision-making processes that affect PAARI programming on a daily basis. “I am a believer […]
PAARI Applauds the FDA in Approving First Over-the-Counter Naloxone Nasal Spray
BOSTON, MA March 29, 2023 – Today, the Food and Drug Administration (FDA) approved Narcan, 4 milligrams (mg) naloxone hydrochloride nasal spray for over-the-counter (OTC), nonprescription, use. The Police Assisted Addiction and Recovery Initiative (PAARI) applauds the FDA for approving this opioid overdose treatment to be available OTC for consumers. PAARI believes that expanding access […]
- « Previous Page
- 1
- …
- 5
- 6
- 7
- 8
- 9
- …
- 23
- Next Page »
